Oncology

Company LogoDublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "RNA Therapies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.RNA Therapies in Oncology: Analytical Tool is the must have handbook for…

Company LogoDublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Antibodies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Conjugated Antibodies in Oncology: Analytical Tool is the must have…

Company LogoDublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.DNA Damage Response (DDR) Drugs in Oncology: Analytical…

Company LogoDublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Bispecific Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Bispecific Molecules in Oncology: Analytical Tool is the must have…

Company LogoDublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Epigenetic Therapies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. In cancer, many aspects of the epigenome, controlled by DNA…

DUBLIN, June 9, 2022 /PRNewswire/ -- The "Bispecific CD3 Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. There is a considerable and robust commercial drug pipeline of T-cell…

DUBLIN, June 16, 2022 /PRNewswire/ -- The "CAR/TCR Therapies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Your CAR/TCR Therapies in Oncology: Analytical Tool covers more than 173 companies…